This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: University of California. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Mohammad Ali Baikoghli
Introduction
Mohammad Ali Baikoghli is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of virus-like nanoparticles for medical applications. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing scientific knowledge.
Latest Patents
Baikoghli holds 2 patents related to his research on Hepatitis E virus (HEV)-based virus-like nanoparticles. His latest patents focus on a novel HEV-based nanoparticle made with a modified capsid protein that contains a portion of the open reading frame 2 (ORF2) protein conjugated with gold nanoclusters. These patents also detail methods for the targeted delivery of nucleic acids using the HEV nanoparticles, which could have significant implications for oral delivery systems in medicine.
Career Highlights
Baikoghli's career is marked by his commitment to research and innovation. He is affiliated with the University of California, where he continues to explore the potential of virus-like nanoparticles in therapeutic applications. His work not only contributes to the scientific community but also aims to improve health outcomes through advanced delivery systems.
Collaborations
Some of Baikoghli's notable coworkers include R Holland Cheng and Chun Chieh Chen. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
In summary, Mohammad Ali Baikoghli is a prominent inventor whose work on virus-like nanoparticles has the potential to revolutionize oral delivery methods in medicine. His contributions to biotechnology are noteworthy and reflect his dedication to advancing healthcare solutions.